RxDoctor Payments Data

Sandra Richman

Internal Medicine · Brookline, MANPI 1023152717

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $885,955 of the $1,431,099 with a category attached, or 61.9%. Blueprint Medicines Corporation accounts for 61.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $374,598 and has fallen 76.9% since, to $86,469 in 2025. Among internal medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,431,099in general payments, 2019–2025

Across 121 payments — averaging $11,827 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Blueprint Medicines Corporation$886K
  • Apellis Pharmaceuticals, Inc.$451K
  • Agios Pharmaceuticals, Inc.$57K
  • Sanofi$37K

What the payments were for

  • Consulting fees$545,14438%
  • Speaking & faculty fees$885,95562%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,431,099 in reported general payments places this provider in the 95th percentile of 4,983 internal medicine providers in Massachusetts.

See all internal medicine providers in Massachusetts

Other internal medicine in Brookline

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →